Trial.ID	Age	Histological.grade	Pathology.Grading.Components_T	Pathology.Grading.Components_P	Pathology.Grading.Components_M	Gender	Histological Subtype	Receptor Subtype	surgery_type	Margin.status	T.Stage	N.stage	M.stage	Paget.disease	DCIS	LCIS	prior_breast_ca	neo_adj_treatment_class	disease_progression_after_VAULT_sample	cause_of_death	recurrence_current_sample_is_recurence	Regimen_neoadj	survival_status_at_last_fu	days_to_first_recurrence	daystolastfollow	stage	Recurrence.score_GEP	GEP_performed
HF004	46	G3	3	3	3	F	IDC_NST	TN	WLE	Un-involved	T1c	N0	M0	Not recorded	Present	Absent	Yes	NA	NO		Yes		Alive	NA	2055	1	0	NA
HF006	57	G2	3	3	1	F	IDC_NST	ER+/HER2-	WLE	Un-involved	T2	N0	NA	Not recorded	Present	Absent	No	NET>30d<90d	NO		No	LETROZOLE	Alive	NA	2186	2	13	Oncotype_Dx
HF007	34	G3	3	2	1	F	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T2	N0	NA	Absent	Present	Absent	No	NA	YES		No		Alive	833	2000	2	6	Oncotype_Dx
HF016	53	G2	3	3	1	F	IDC_NST	ER+/HER2-	WLE	Un-involved	T4	N0	NA	Not recorded	Absent	Absent	No	NA	YES	Other	No		Dead_not_cancer_related	37	360	3	14	Oncotype_Dx
HF017	44	G1	2	2	1	F	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T2	N0	NA	Not recorded	Present	Present	No	NA	NO		No		Alive	NA	1867	2	0	NA
HF031	55	G3	3	3	3	F	IDC_NST	HER2+	WLE	less than/ equal to 1mm	T2	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1825	2	0	NA
HF032	42	G3	3	3	2	F	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T4	N2a	M0	Absent	Present	Absent	No	NA	YES	Cancer related	No		Dead_cancer_related	393	851	3	0	NA
HF033	71	G2	3	2	1	F	IDC_NST	ER+/HER2-	WLE	Un-involved	T2a	N1a	NA	Not recorded	Absent	Absent	No	NA	NO		No		Alive	NA	1852	2	0	NA
HF036	53	G2	3	2	1	F	ILC	ER+/HER2-	Mastectomy	Involved	T3	N0(i+)	Mx	Not recorded	Absent	Absent	Yes	NET>90d	YES		Yes	LETROZOLE	Alive	761	1942	2	0	NA
HF039	63	G3	3	3	2	F	ILC	ER+/HER2-	Mastectomy	Un-involved	T4	N0	M0	Not recorded	Absent	Present	No	SACT_NET>90d	NO		No	LETROZOLE,FULVESTRANT,RIBOCICLIB,LETROZOLE,EVEROLIMUS,EXEMESTANE	Alive	NA	1793	3	0	NA
HF041	63	G3	3	2	3	F	IDC_NST	ER+/HER2-	WLE	Un-involved	T2	N0	NA	Not recorded	Present	Absent	No	NET<30d	NO		No	LETROZOLE	Alive	NA	1910	2	27	Oncotype_Dx
HF044	56	G3	3	3	2	F	ILC	ER+/HER2-	Mastectomy	Involved	T3	N1x	M0	Absent	Absent	Present	No	NA	YES	Mestatic Disease	No		Dead_cancer_related	777	1902	3	0	NA
HF052	51	G2	3	2	1	F	MixedILC/IDC	ER+/HER2-	Mastectomy	less than/ equal to 1mm	T3	N2a	M0	Not recorded	Present	Present	No	NA	YES		No		Alive	1806	1936	3	0	NA
HF057	71	G3	3	3	2	F	ILC	ER+/HER2-	WLE	Involved	T2	N0	M0	Not recorded	Absent	Absent	Yes	NA	YES		Yes		Alive	127	2092	2	0	NA
HF068	72	G2	3	3	1	F	IDC_NST	HER2+	Mastectomy	Un-involved	T2	N1a	M0	Not recorded	Present	Absent	No	NET>90d	NO		No	LETROZOLE,EXEMESTANE	Alive	NA	1794	2	0	NA
HF079	59	G2	3	2	1	F	IDC_NST	ER+/HER2-	WLE	Un-involved	T2	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1858	2	0	NA
HF083	54	G2	3	2	1	F	ILC	ER+/HER2-	Mastectomy	Un-involved	T2	N0	NA	Not recorded	Absent	Present	No	NA	NO		No		Alive	NA	1349	2	17	Oncotype_Dx
HF104	75	G2	3	2	1	F	IDC_NST	ER+/HER2-	WLE	Involved	T2	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1819	2	0	NA
HF105	76	G3	3	3	2	F	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T2	N0	NA	Not recorded	Present	Absent	Yes	NET>30d<90d	NO	Other	No	LETROZOLE	Dead_not_cancer_related	NA	814	2	0	NA
HF106	72	G3	3	3	2	F	IDC_NST	TN	WLE	Un-involved	T2	N0	NA	Not recorded	Absent	Absent	No	NA	NO		No		Alive	NA	1573	2	0	NA
HF124	44	G3	3	3	2	F	IDC_NST	ER+/HER2-	Mastectomy	Involved	T3	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1707	2	27	Oncotype_Dx
HF125	65	G3	3	3	3	F	IDC_NST	ER+/HER2-	WLE	less than/ equal to 1mm	T2	N1a	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1467	2	0	NA
HF127	54	G2	3	3	1	F	IDC_NST	HER2+	WLE	less than/ equal to 1mm	T2	Nx	M1	Not recorded	Present	Absent	Yes	NET<30d	YES		No	LETROZOLE	Alive	100	1735	4	0	NA
HF132	53	G2	3	2	1	F	MixedILC/IDC	ER+/HER2-	Mastectomy	Un-involved	T4b	N2a	M1	Not recorded	Absent	Absent	No	SACT	YES	Cancer related	No	PALBOCICLIB,TAMOXFIEN,GOSERELIN,CAPECITABINE	Dead_cancer_related	139	549	4	0	NA
HF134	52	G2	3	2	1	F	ILC	ER+/HER2-	WLE	Involved	T3	N1a	M0	Not recorded	Absent	Present	No	NA	NO		No		Alive	NA	1597	3	0	NA
HF136	59	G1	1	2	1	F	IDC_NST	HER2+	WLE	Un-involved	T1c	N1a	M0	Not recorded	Present	Absent	No	SACT	NO		No	DOCETAXEL,TRASTUZUMAB,PERTUZUMAB,EPIRUBICIN,CYCLOPHOSPHAMIDE	Alive	NA	1510	2	0	NA
HF149	80	G2	3	2	1	M	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T2	N0	NA	Absent	Present	Absent	No	NA	NO		No		Alive	NA	944	2	0	NA
HF159	77	G2	3	2	1	F	ILC	ER+/HER2-	WLE	less than/ equal to 1mm	T3a	N0	M0	Not recorded	Absent	Present	Yes	NET<30d	NO		No	LETROZOLE	Alive	NA	1393	2	0	NA
HF168	54	G3	3	3	3	F	IDC_NST	ER+/HER2-	WLE	less than/ equal to 1mm	T2	N1a	Mx	Not recorded	Present	Absent	No	NA	YES	Cancer related	No		Dead_cancer_related	261	278	2	0	NA
HF169	56	G3	3	3	3	F	IDC_NST	ER+/HER2-	WLE	less than/ equal to 1mm	T2	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1631	2	31	Oncotype_Dx
HF170	58	G2	3	2	1	F	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T3	N2a	M0	Not recorded	Present	Absent	No	NET>30d<90d	YES		No	TAMOXIFEN	Alive	1343	1653	3	0	NA
HF176	95	G2	3	2	1	F	IDC_NST	ER+/HER2-	WLE	Un-involved	T1c	Nx	NA	Not recorded	Absent	Present	No	NET>90d	NO		No	LETROZOLE	Alive	NA	1256	1	0	NA
HF178	78	G3	3	3	3	F	IDC_NST	TN	WLE	Involved	T2	N0	NA	Not recorded	Present	Present	Yes	NA	NO		No		Alive	NA	1324	2	0	NA
HF181	67	G2	3	3	1	F	IDC_NST	ER+/HER2-	WLE	Un-involved	T1c	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1465	1	16	Oncotype_Dx
HF195	87	G2	3	2	1	F	ILC	ER+/HER2-	Mastectomy	Involved	T4b	N2a	M0	Not recorded	Absent	Present	No	NET>90d	YES	Unknown Cancer related	No	LETROZOLE,EXEMESTANE	Dead_cancer_related	395	990	3	0	NA
HF199	47	G2	3	3	1	F	IDC_NST	ER+/HER2-	Mastectomy	less than/ equal to 1mm	T2	N2a	M1	Not recorded	Present	Absent	No	NA	YES		No		Alive	25	1607	4	0	NA
HF200	63	G3	3	3	3	F	MucinousCarcinoma	HER2+	Mastectomy	less than/ equal to 1mm	T2	N0	M0	Absent	Present	Absent	No	NA	NO		No		Alive	NA	1445	2	0	NA
HF206	56	G3	3	3	3	F	ILC	ER+/HER2-	WLE	less than/ equal to 1mm	T3	N0	M0	Not recorded	Absent	Absent	No	NA	NO		No		Alive	NA	1579	2	0	NA
HF221	47	G2	2	3	1	F	IDC_NST	ER+/HER2-	Mastectomy	less than/ equal to 1mm	T2	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	668	2	38	Prosigna
HF222	72	G2	3	3	1	F	IDC_NST	ER+/HER2-	WLE	Involved	T2	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1516	2	62	Prosigna
HF231	51	G2	3	2	2	F	IDC_NST	ER+/HER2-	WLE	Un-involved	T2	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1463	2	62	Prosigna
HF238	50	G2	3	2	1	F	ILC	ER+/HER2-	WLE	Involved	T3	N0	NA	Not recorded	Present	Present	No	NET<30d	NO		No	TAMOXIFEN	Alive	NA	1449	2	33	Prosigna
HF246	64	G2	3	2	1	F	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T2	N0	M0	Absent	Present	Present	Yes	NET<30d	YES	Not exactly known. Possible cardiovascular event. Not cancer related.	No	LETROZOLE	Dead_not_cancer_related	978	1034	2	36	Prosigna
HF247	40	G2	3	2	1	F	ILC	ER+/HER2-	Mastectomy	less than/ equal to 1mm	T3	N0	M0	Not recorded	Present	Present	No	NET<30d	NO		No	TAMOXIFEN	Alive	NA	1094	2	32	Prosigna
HF250	55	G3	3	3	2	F	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T1c	N1a	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1497	2	0	NA
HF251	79	G2	3	2	1	F	IDC_NST	ER+/HER2-	Mastectomy	Not recorded	T2	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1350	2	0	NA
HF252	53	G1	2	2	1	F	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T3	N0	NA	Absent	Present	Absent	No	NA	NO		No		Alive	NA	1429	2	0	NA
HF255	53	G3	3	3	2	F	IDC_NST	ER+/HER2-	Mastectomy	less than/ equal to 1mm	T3	N2a	NA	Absent	Present	Absent	No	SACT	YES		No	EPIRUBICIN,CYCLOPHOSPHAMIDE,PACLITAXEL	Alive	514	1488	3	0	NA
HF268	50	G3	3	3	3	F	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T2	N1a	M0	Absent	Present	Absent	No	NA	NO		No		Alive	NA	1437	2	0	NA
HF270	64	G2	3	3	1	F	ILC	ER+/HER2-	Mastectomy	Involved	T2	N1a	M0	Not recorded	Absent	Present	No	SACT	NO		No	EPIRUBICIN,CYCLOPHOSPHAMIDE,PACLITAXEL	Alive	NA	1367	2	0	NA
HF272	71	G2	3	2	1	F	MixedILC/IDC	ER+/HER2-	WLE	Involved	T2	N0	M0	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1184	2	67	Prosigna
HF276	42	G2	3	2	1	F	IDC_NST	ER+/HER2-	WLE	Involved	T2	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1428	2	0	NA
HF279	61	G3	3	3	3	F	IDC_NST	ER+/HER2-	WLE	less than/ equal to 1mm	T2	Nx	M0	Absent	Absent	Absent	Yes	NA	YES		Yes		Alive	226	1434	2	72	Prosigna
HF283	50	G3	3	3	3	F	IDC_NST	ER+/HER2-	WLE	less than/ equal to 1mm	T3	N1a	NA	Not recorded	Present	Absent	No	NET<30d	NO		No	TAMOXIFEN	Alive	NA	1276	3	0	NA
HF291	69	G3	3	3	2	F	MixedILC/IDC	HER2+	Mastectomy	less than/ equal to 1mm	T3	N3a	M0	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1303	3	0	NA
HF299	67	G3	3	3	2	F	MixedILC/IDC	ER+/HER2-	WLE	Un-involved	T3	N3	NA	Not recorded	Present	Present	No	NET>30d<90d	YES	Cancer related	No	LETROZOLE	Dead_cancer_related	149	277	3	0	NA
HF328	45	G2	3	2	1	F	ILC	ER+/HER2-	Mastectomy	Involved	T3	N2x	M0	Not recorded	Present	Present	No	NA	NO		No		Alive	NA	1275	3	0	NA
HF350	77	G3	3	3	2	F	IDC_NST	ER+/HER2-	Mastectomy	Involved	T2	N1	M0	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	1073	2	0	NA
HF374	76	G1	2	2	1	F	IDC_NST	ER+/HER2-	Mastectomy	Involved	T1b	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	678	1	0	NA
HF388	57	G3	3	3	3	F	IDC_NST	ER+/HER2-	Mastectomy	Involved	T2	N1a	M0	Not recorded	Absent	Absent	No	NET<30d	NO		No	LETROZOLE	Alive	NA	811	2	0	NA
HF389	67	G3	3	3	3	F	IDC_NST	HER2+	Mastectomy	less than/ equal to 1mm	T2	N0	M0	Not recorded	Present	Present	No	NA	NO		No		Alive	NA	362	2	0	NA
HF390	67	G2	3	2	1	F	ILC	ER+/HER2-	Mastectomy	Involved	T3	N2	M0	Not recorded	Present	Present	No	NA	NO		No		Alive	NA	874	3	0	NA
HF394	69	G3	3	3	2	M	IDC_NST	ER+/HER2-	Mastectomy	Involved	T1c	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	775	1	57	Prosigna
HF395	57	G3	3	3	3	F	IDC_NST	ER+/HER2-	WLE	Involved	T1c	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	890	1	80	Prosigna
HF401	61	G2	2	3	1	F	IDC_NST	HER2+	Mastectomy	Un-involved	T1c	N0	NA	Not recorded	Present	Absent	No	NA	NO		No		Alive	NA	879	1	0	NA
HF414	61	G3	3	3	3	F	IDC_NST	HER2+	WLE	Un-involved	T2	N1	NA	Present	Present	Absent	No	NA	NO		No		Alive	NA	682	2	0	NA
HF419	62	G2	3	2	1	F	ILC	ER+/HER2-	Mastectomy	Un-involved	T2	N0	NA	Not recorded	Absent	Present	No	NET<30d	NO		No	LETROZOLE	Alive	NA	791	2	0	NA
HF420	61	G2	3	2	1	F	IDC_NST	ER+/HER2-	Mastectomy	Un-involved	T2	N1	M0	Not recorded	Present	Absent	No	NET>30d<90d	NO		No	LETROZOLE	Alive	NA	769	2	0	NA
HF422	66	G2	3	2	1	F	ILC	ER+/HER2-	WLE	Un-involved	T3	N0	NA	Not recorded	Absent	Present	No	NA	NO		No		Alive	NA	442	2	0	NA
HF424	58	G2	3	3	1	F	IDC_NST	ER+/HER2-	WLE	Un-involved	T2	N2a	NA	Not recorded	Present	Absent	No	NET<30d	NO		No	LETROZOLE	Alive	NA	704	3	0	NA
